Question 1

What specific types of advanced solid tumors does this trial focus on?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the AK129 Combination Therapy for Advanced Solid Tumors clinical trial (NCT06943820). Contact the study team or your healthcare provider for specific answers.

Question 2

How does AK129 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the AK129 Combination Therapy for Advanced Solid Tumors clinical trial (NCT06943820). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the AK129 Combination Therapy for Advanced Solid Tumors clinical trial (NCT06943820). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the AK129 Combination Therapy for Advanced Solid Tumors clinical trial (NCT06943820). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the expected duration of the treatment in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the AK129 Combination Therapy for Advanced Solid Tumors clinical trial (NCT06943820). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any additional tests or procedures I would need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the AK129 Combination Therapy for Advanced Solid Tumors clinical trial (NCT06943820). Contact the study team or your healthcare provider for specific answers.

What this study is about